Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by scarlet1967on Jan 28, 2021 7:55pm
138 Views
Post# 32416364

RE:Repeated mistakes are not "mistakes"

RE:Repeated mistakes are not "mistakes"The idea is to learn from others mistake to avoid making same mistakes.
But unfortunately most peaple think they know better ,make same mistakes,pay the price and change.
But some are stubborn enough not to acknowledge their mistakes and keep making wrong decisions and those people are exactly what you said.
We need either a fundamental change of how this company conduct their business or new leadership.



JayjayUSA12007 wrote: For more than 10 years, with repeated mistakes after mistakes, let's call it a proper name. It's incompetence, ignorance, idiocy or stupidity.
While the science guys seemed to know what they were doing, Thera financial guy(s) and marketing guy(s) did not seem to know what they are doing. It's rebundantly clear that an offering would be a lot better in the US market than the Canadian market. It's is the financial guy's job to find that deal, since he got paid to do so. If he couldn't while others could, is he worthed his paycheck ?
Time for deadwood removal...


<< Previous
Bullboard Posts
Next >>